Changes in Hong Kong stocks | FuRui Medical Technology (01696) fell nearly 6% and is expected to change from profit to loss in the first half of the year. The North American market faces a severe environment and sales decline

The Zhitong Finance App learned that FuRui Medical Technology (01696) fell nearly 6%. As of press release, it fell 5.87% to HK$2,325, with a turnover of HK$1.6653 million.

According to the news, on August 3, FuRui Medical Technology issued a profit warning. The Group expects revenue of no less than US$171 million for the first half of 2026 and US$166 million for the same period in 2025, but losses attributable to the owners of the company are about US$900,000 to US$1.4 million, which is a loss compared to a profit of US$6.4 million for the same period last year.

The main causes of losses included a decline in sales due to the continued severe operating environment in the North American market, and the company's continued investment in the injection-filling business in mainland China. The company said it is optimizing commercialization efficiency in North America, promoting cost control, and speeding up the promotion of Dashfield products and the construction of production capacity in China.